InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59
United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

53
Insider
Date
Role
Action
Shares
Price
Amount
Leonard E Post
15 Oct 2026
Director
Sold after exercise
500
$62.48
$31.24K
Leonard E Post
15 Oct 2026
Director
Sold after exercise
500
$61.65
$30.83K
Leonard E Post
15 Sep 2026
Director
Sold after exercise
1,000
$72.98
$72.98K
Leonard E Post
14 Aug 2026
Director
Sold after exercise
1,000
$74.54
$74.54K
Leonard E Post
15 Jul 2026
Director
Sold after exercise
1,000
$71.17
$71.17K
James Mulay
10 Jul 2026
Director
Sold after exercise
24,165
$75.16
$1.82M
Brian Guan-Chyun Liu
25 Jun 2026
Director
Buy indirect
371,085
$66.87
$24.81M
Leonard E Post
24 Jun 2026
Director
Sold after exercise
5,000
$70.00
$350.00K
Leonard E Post
22 Jun 2026
Director
Sold after exercise
5,000
$65.00
$325.00K
James Mulay
15 Jun 2026
Director
Sold after exercise
1,310
$60.12
$78.76K
James Mulay
15 Jun 2026
Director
Sold after exercise
654
$60.12
$39.32K
Leonard E Post
4 Jun 2026
Director
Sold after exercise
1,000
$54.50
$54.50K
James Mulay
17 Apr 2026
Director
Sold after exercise
15,600
$73.01
$1.14M
James Mulay
16 Mar 2026
Director
Sold after exercise
1,310
$63.50
$83.19K
James Mulay
16 Mar 2026
Director
Sold after exercise
654
$63.50
$41.53K
Arthur Kuan
12 Mar 2026
Chief Executive Officer
Exercised, kept
64,612
$1.72
$111.13K
Arthur Kuan
4 Mar 2026
Chief Executive Officer
Exercised, kept
102,871
$1.72
$176.94K
James Mulay
9 Jan 2026
Director
Sold after exercise
10,491
$52.99
$555.92K
James Mulay
9 Jan 2026
Director
Sold after exercise
654
$44.16
$28.88K
Leonard E Post
17 Nov 2025
Director
Sold after exercise
1,000
$41.43
$41.43K
Leonard E Post
13 Oct 2025
Director
Sold after exercise
1,000
$43.25
$43.25K
James Mulay
9 Oct 2025
Director
Sold after exercise
5,903
$43.99
$259.67K
Leonard E Post
30 Sep 2025
Director
Sold after exercise
5,000
$40.09
$200.45K
James Mulay
29 Sep 2025
Director
Sold after exercise
12,755
$39.19
$499.87K
James Mulay
19 Sep 2025
Director
Sold after exercise
3,574
$38.99
$139.35K
James Mulay
18 Sep 2025
Director
Sold after exercise
19,112
$39.01
$745.56K
Leonard E Post
15 Sep 2025
Director
Sold after exercise
1,000
$35.10
$35.10K
Brian Guan-Chyun Liu
11 Sep 2025
Director
Buy indirect
1,515,151
$33.00
$50.00M
James Mulay
5 Sep 2025
Director
Sold after exercise
3,113
$33.22
$103.41K
James Mulay
5 Sep 2025
Director
Sold after exercise
7,465
$32.64
$243.66K
James Mulay
5 Sep 2025
Director
Sold after exercise
4,095
$31.42
$128.66K
James Mulay
5 Sep 2025
Director
Sold after exercise
12,342
$30.47
$376.06K
Leonard E Post
3 Sep 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
100
$28.99
$2.90K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
100
$28.96
$2.90K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
30,105
$28.24
$850.17K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
69,695
$27.60
$1.92M
Leonard E Post
17 Jul 2025
Director
Sold after exercise
2,000
$28.00
$56.00K
Leonard E Post
21 May 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
Leonard E Post
28 Apr 2025
Director
Sold after exercise
1,000
$30.76
$30.76K
Leonard E Post
17 Mar 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
Leonard E Post
18 Feb 2025
Director
Sold after exercise
1,000
$28.61
$28.61K
Leonard E Post
13 Jan 2025
Director
Sold after exercise
1,000
$29.66
$29.66K
Leonard E Post
16 Dec 2024
Director
Sold after exercise
1,000
$28.84
$28.84K
Hong Fang Song
16 Dec 2024
Director
Sell indirect
700,000
$28.00
$19.60M
Leonard E Post
6 Dec 2024
Director
Sold after exercise
250
$34.98
$8.74K
Leonard E Post
6 Dec 2024
Director
Sold after exercise
750
$34.40
$25.80K
Hong Fang Song
29 Aug 2024
Director
Sell indirect
226,245
$35.36
$8.00M
Hong Fang Song
29 Aug 2024
Director
Sell indirect
424,210
$35.36
$15.00M
Decheng Capital Global Life Sciences Fund IV, L.P.
29 Jan 2024
10% owner
Buy indirect
400,000
$19.00
$7.60M
Hong Fang Song
29 Jan 2024
Director
Buy
263,157
$19.00
$5.00M
Corleen M. Roche
29 Jan 2024
CFO & Secretary
Buy
2,000
$19.00
$38.00K
Vijay Kasturi
29 Jan 2024
Chief Medical Officer
Buy
1,315
$19.00
$24.99K

What was left out

Form 4 filings counted 76
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 38
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,248,735
History held since 26 Jan 2024